Say No to DRx , use Pharmacist

DRx can have different meanings depending on the context, most commonly referring to "Drug Expert," a prefix used by some pharmacists in India to signify their professional expertise. 

As "Drug Expert" (Pharmacists) 

         Meaning: 

• The full form is DRug eXpert.   
• Purpose: 
• It is used by pharmacists to indicate their knowledge and expertise in medications and drug therapy, as well as their licensed and registered status. 
• Usage: 
• This is an informal prefix and not officially recognized by the Pharmacy Council of India, although it is gaining traction among pharmacists, especially in India. It is not the same as the "Dr." title for medical doctors. 
• 
  
• Eligibility: 
• Those who have completed professional pharmacy courses like B.Pharm and M.Pharm can use the title. 

don't rent your pharmacy license

Difference Between PCD(Propaganda Cum Distribution)(Standard) , Generic, and Ethical Pharma Sectors

Difference Between PCD, Generic, and Ethical Pharma Sectors

Difference between PCD, Generic, and Ethical Pharma Sectors? – The pharmaceutical industry is quite large. There are a lot of small enterprises and sectors inside it, which are in major focus. Across all sectors, Pharma Franchise and PCD Pharma Franchise are prominent. 

Simultaneously, the pharmaceutical industry is directly linked with the nation’s economic growth, which is an extra factor that boosts the popularity of the pharmaceutical business sector.

Difference Between PCD, Generic, and Ethical Pharma Sectors

It is necessary to distinguish between PCD, generic, and ethical pharma sectors. There is a wide difference between the three here.

1. PCD (Propaganda- Cum- Distribution)

PCD stands for propaganda-less distribution means a type of sector in which a pharma company contracts a franchise agreement with a person or group of people.

The PCD franchise business deals with marketing and distribution rights for products by the parent pharma company.

Under the PCD model, the entrepreneur is required to purchase the franchise rights of a pharma company and start selling their products. They usually interact to physicians and doctors to promote the company’s products.

A person, who wants to start a firm in this field, needs to invest a lesser amount. In addition, marketing and promotional costs will also be provided by the pharma company only.

2. Generic Sector

In this generic pharma sector, generic drugs are manufactured by a pharma company and sold directly to retailers with distribution channels and sales representatives support.

Generic medicines use a similar administration route and simultaneously display the brand name of the products. In addition, they have similar quality and performance levels. 

The advantage of being in the generic sector is that generic medicines are priced lower than branded drugs. It is an economically effective and efficient business.

Sometimes the making process can also change, which affects the cost of the drug. The cost of generic medicines is held much lower than that of branded medicines.

3. Ethical Pharma Sector

Ethical pharma is the traditional and most popular part of the pharma industry. Here, all types of medicinal medicines are spread through medical representatives.

Medical representatives share all necessary information with doctors. They aim to convince doctors about the merits of the products over others.

There are many marketing techniques and methods used with the doctor to promote a specific drug range.

Conclusion: 

PCD, generic, and ethical pharma are all three different types of business practices. However, the general point is that they all belong to the pharma family and have different distribution channels

PCD Pharma Model (Standard Pharma Products)

PCD in pharma stands for Propaganda Cum Distribution, which refers to a business model where a pharmaceutical company grants a franchisee the right to promote and distribute its products in a specific region. In this franchise system, the franchisee handles the marketing (promotion) and sales of the company's medicines without needing to establish a separate manufacturing unit, making it a low-investment option for entrepreneurs. 

• Propaganda: In this context, "propaganda" means the promotion and marketing of products, not misleading information. It involves activities like building brand awareness among healthcare professionals and consumers.
• Distribution: This refers to the actual distribution and sale of the pharmaceutical products within a defined geographical area.
• Franchise model: PCD is a type of franchise, where the parent company provides its brand, products, and sometimes marketing support to the franchisee, who operates with the established brand name and image.
• Benefits: This model is often attractive to individuals and smaller companies because it requires a lower initial investment compared to starting a full-fledged pharmaceutical company. The franchisee can also benefit from the parent company's brand reputation and an exclusive range of products. 

• - 
• PCD Pharma: This model, sometimes considered a "standard" business approach, involves marketing and distribution without significant R&D investment. A company gets the right to sell a parent company's products in a specific territory.

difference between Ethical , Standard and Generic pharma products

Ethical pharma focuses on innovation, research, and development of new, patented drugs, while generic pharma manufactures affordable, off-patent versions of these drugs. "Standard" is not a standard industry term for a type of pharmaceutical product; instead, it's more accurately understood in contrast to ethical and generic drugs as a potential way of referring to a non-promotional, or "PCD" (Propaganda-cum-Distribution) model, or simply a category of approved, quality-assured medicines. 

Feature	Ethical Pharma	Generic Pharma
Focus	Research and development of new, patented drugs.	Production of affordable, off-patent alternatives.
Cost	Higher, due to R&D and marketing costs.	Lower, due to the absence of R&D and patent costs.
Examples	New cancer treatments or vaccines.	A generic version of a branded medication, like Metformin being sold as Glucophage.
Marketing	Heavily marketed to healthcare professionals.	Focuses on cost-effectiveness and wide distribution.
Regulation	Subject to strict regulations for drug development and clinical trials.	Must meet drug equivalency standards to prove they are bioequivalent to the original drug.

Understanding "standard":

• PCD Pharma: This model, sometimes considered a "standard" business approach, involves marketing and distribution without significant R&D investment. A company gets the right to sell a parent company's products in a specific territory.
• Quality Assurance: In a general sense, all ethical and generic drugs approved by regulatory bodies are "standard" in that they have met the required safety, efficacy, and quality standards. 

Key takeaway: The primary distinction is between innovating new drugs (ethical) and producing affordable, bioequivalent copies (generic). 

What is the Difference Between Generic And Ethical Medicine?

• Posted By Sumesh Sharma

In This Article

1. What Are Ethical Medicines?
   1. What Are Generic Medicines?
   2. Differences Between Generic and Ethical Medicines
   3. Generic Vs Ethical Medicine In Pharma
      1. Final Thought 

What is the Difference Between Generic And Ethical Medicine? The pharmaceutical industry serves as a backbone for healthcare worldwide, delivering medicines to treat, manage, and prevent diseases. Among the vast categories of medications, generic and ethical medicines are the most prominent. While both aim to provide effective healthcare, their production, marketing, and distribution differ significantly. Understanding the difference between generic and ethical medicine can guide consumers, healthcare providers, and pharma professionals in making informed decisions.

This blog explores the differences between generic and ethical medicines, focusing on their definitions, cost structures, accessibility, regulations, and more.

What Are Ethical Medicines?

Ethical medicines, often referred to as branded or innovator drugs, are produced by pharmaceutical companies that have developed the product through extensive research and trials. 

These medicines are protected by patents, giving the company exclusive manufacturing and distribution rights for a set period.

Key Features of Ethical Medicines

1. Innovative: Result from years of research aimed at addressing specific medical needs.
2. Higher Costs: Pricing reflects R&D, marketing, and patenting investments.
3. Exclusive Branding: Marketed under unique names to build trust and recognition.
4. Limited Accessibility: Available only through prescriptions, ensuring controlled usage.

What Are Generic Medicines?

Generic medicines are alternatives to branded drugs that become available after the patent of the original product expires. These medicines must meet strict bioequivalence standards, ensuring that they are as effective and safe as the branded versions.

Key Features of Generic Medicines

1. Same Active Ingredients: They have identical active components to their branded counterparts.
2. Cost-Effective: Without marketing or R&D expenses, these medicines are significantly cheaper.
3. Widespread Availability: Easily accessible in pharmacies, making them an affordable option for many.
4. Regulated Quality: National health authorities, such as the FDA in the USA and CDSCO in India, oversee production to ensure high-quality standards.

Differences Between Generic and Ethical Medicines

Aspect	Generic Medicines	Ethical Medicines
Cost	Affordable due to low overhead expenses.	Higher cost due to R&D and branding investments.
Regulatory Approval	Requires bioequivalence tests.	Requires extensive clinical trials and studies.
Patent Protection	No patent protection; introduced after the original patent expires.	Protected by patents, offering exclusivity.
Marketing	Minimal promotion; relies on affordability and utility.	Heavily marketed to healthcare providers and consumers.
Accessibility	Readily available over the counter or with prescriptions.	Strictly available through prescriptions.

Generic Vs Ethical Medicine In Pharma

The Generic Pharma Business focuses on producing affordable, off-patent medications that match branded drugs in quality and effectiveness. It emphasises cost efficiency, large-scale production, and wide distribution, often catering to lower-income demographics and healthcare systems.

The Ethical Pharma Business, however, develops innovative medicines backed by extensive research and clinical trials. These drugs are patented, heavily marketed to healthcare professionals, and sold at higher prices to recover R&D costs.

Both business models play vital roles in healthcare, with generics ensuring accessibility and ethical pharma driving innovation.

Pharmacare Awareness Rallies are different from Healthcare Awareness Rallies

Pharmacare Awareness Rallies are different from Healthcare Awareness Rallies

"Prescription is decided by the doctor, but the brand of medicine should be chosen by the patient with the help of a pharmacist, based on the patient’s income."

"Prescription is decided by the doctor, but the brand of medicine should be chosen by the patient with the help of a pharmacist, based on the patient’s income."

🔍 1. Role of the Doctor:

Doctors are responsible for diagnosing the illness and prescribing the generic name of the medicine (e.g., Paracetamol, Amoxicillin).

This ensures that the treatment is medically appropriate and based on clinical judgment.

💊 2. Role of the Pharmacist:

A qualified pharmacist is trained in pharmacology, drug interactions, and therapeutic alternatives.

In #communitypharmacy practice, pharmacists help patients choose from available brands of the prescribed generic medicine.

They consider:

1. Patient’s income level

2.Availability of brands

3. Quality and reputation of manufacturers

Patient preferences (e.g., tablet size, packaging, ease of use)

👥 3. Role of the Patient:

The patient has the right to be informed and involved in the decision-making process.

With guidance from the pharmacist, the patient can select a brand that is affordable and effective, rather than being forced to buy a specific brand that may be expensive or unavailable.

⚖️ 4. Legal and Ethical Basis:

According to Pharmacy Practice Regulations and Pharmaceutical Jurisprudence in India:

Doctors are encouraged to prescribe generic names.

Pharmacists are legally allowed to dispense any brand of the prescribed generic, unless the prescription explicitly prohibits substitution.

This model promotes rational drug use, cost-effectiveness, and patient empowerment.

This model promotes rational drug use, cost-effectiveness, and patient empowerment.

It reduces healthcare costs and ensures access to essential medicines for all income groups.

This approach aligns with the principles of community pharmacy, where:

Doctors diagnose and prescribe generics.

Pharmacists guide brand selection.

Patients make informed choices based on affordability and need.

It promotes transparency, accessibility, and collaborative care—the foundation of a strong healthcare system.

Thanks

Rohit Gupta, Pharma Expert

The Power Shift : from Physicians to Pharmacists

Is it GAME OVER for Physicians ?

In India, big pharmaceutical companies are struggling to do business compared to small, room-based local companies. Everyone knows the reason money matters more than quality. That's why patients should choose their medicine brands with the help of registered pharmacists (RPh).

In which book: brand names of medicines given, and how do Drs decide their quality, Is there any specific subject available, If No, then please prescribe Gen-medicines

ऐसा कौन सा ब्रांड प्रिस्क्राइब किया जाता है जो सिर्फ़ अस्पताल या क्लिनिक में ही मिलता है? समझ नहीं आया। क्या इनोवेटर्स का कोई नया ब्रांड आ गया है? अगर हाँ, तो कृपया जानकारी दें।😃

Brands matter because of quality, agreed. But why so many doctors prescribing branded products from local companies instead of Indian MNCs or global MNCs, I really don’t understand the logic. Poor-quality medicines are harming innocent patients.

POV: Rohit Gupta

Indian FDA(The "Indian FDA" is not a single entity but refers to the Central Drugs Standard Control Organisation (CDSCO), the national regulatory body for drugs, medical devices, and cosmetics in India) Vs USFDA

#IndianFDAVsUSFDA.

source:ChatGPT

Quote'

1. In 2005, there were 3 infants aged under 6 months in the US where cough & cold medications were determined by medical examiners or coroners to be the underlying cause of death. 

2. More broadly, in that period (2004-2005), about 1,519 children under age 2 were treated in US emergency departments for adverse events including overdoses from cough and cold medications. 

3. In the 1930s, there were more than 100 deaths (mostly children) in the US from #DiethyleneGlycol (DEG) poisoning, including from Elixir Sulfanilamide, which was given for coughs/sore throats. That tragedy helped lead to major drug safety laws. 

4. There is no recent public record I found that gives a reliable count of how many deaths from FDA-approved or FDA-regulated cough syrups have occurred in, say, the last 10–20 years in the US specifically attributed to either contamination or misuse.

5. Many of the recent deaths globally from toxic cough syrups have been linked to products from outside the US. 

6. The most noteworthy fact is that

 the contaminated products which caused recent deaths abroad have not and cannot  entere the US drug supply chain.

Unquote'

Now the million dollar questions :

  i. Are we deficient in technology?

  ii. Are our Regulators deficient in 

       quality or in Character?

  iii  Are our FDA officers are as 

        accountable as their 

        counterparts in US - FDA

   iv. Are our Drug Laws are so weak 

         to let loose all lapse?

     v. Don't we have strong political 

          will to adopt Zero-Tolerance?

There are two institutions meant to safeguard the pharmacy profession and the integrity of medicines:

A. Department of Food and Drug Control

B. State Pharmacy Council

Both these institutions have their own inspectors.

Yet, despite that, medical shops continue to operate freely and openly even in the prolonged absence of pharmacists.

Due to the fear of pharmacy inspectors, the attendance of pharmacists in medical shops had slightly improved for some time.

However, after the government took over control of the State Pharmacy Council, inspectors have been left without an effective system to perform their duties, and once again, license conditions are being openly flouted, with unauthorized or fake persons running medical stores, posing a serious public health risk.

The Drugs Inspectors are unable to stop this menace.

It is also unfortunate that pharmacy-based NGOs in the state — such as the Indian Pharmaceutical Association and the Registered Pharmacists Association — have failed to rise issues affecting public health and patients safety..

POV: Bhagwan PS

The "Indian FDA" is not a single entity but refers to the Central Drugs Standard Control Organisation (CDSCO), the national regulatory body for drugs, medical devices, and cosmetics in India. It serves a similar function to the U.S. FDA, ensuring the safety, efficacy, and quality of medical products. In addition, individual states, like Maharashtra, have their own state-level "FDA" to handle state-specific food, drug, and cosmetic regulations.  

National regulatory authority Central Drugs Standard Control Organisation (CDSCO): 

The national regulatory authority responsible for ensuring the safety, efficacy, and quality of drugs, cosmetics, and medical devices throughout India.
Role: 
CDSCO regulates the quality of medical products through the implementation of the Drugs and Cosmetics Act, 1940.
Headquarters: 
Located in New Delhi.
Drug Controller General of India (DCGI): 
The executive head of the CDSCO, who is responsible for regulating pharmaceutical and medical devices. State-level authorities

State FDA: 
Many states have their own Food and Drug Administration (FDA) to enforce regulations at the state level.
Example: 
The Food and Drug Administration, Maharashtra is an example of a state-level body responsible for food and drug safety within Maharashtra. Other international relevance

U.S. FDA India Office: The U.S. FDA also has an office in New Delhi to ensure that food and medical products exported from India to the U.S. meet U.S. safety standards. 

Pharma Scandals and Loopholes

Pharmacy - Ajeeb daastaan hy ye...

- kahaa shuru kahaa khatam

👉🏼 Pharmacists lending degree  PhD certificates to colleges, while working elsewhere and appearing in person only on Inspection day.

👉🏼Postfacto signing of all registers and records of the college a day before inspection day.

👉🏼 PCI inspectors ignoring lapses and deficiencies and sending Ok report to PCI for approval or renewal of the College

👉🏼Pharmacists lending Regn certificate to retailers while working elsewhere.

👉🏼 Drugs inspectors suppressing the Pharmacist's absence and allowing dispensing without Pharmacists.

👉🏼PCI and State Regulatory Officers working on paper bundles (false reports) to justify salary of establishment 😄

👉🏼Acts, Rules, Regulations have become Arterial circulation to energise officers to make money

👉🏼Money Money  Money - Venous circulation - to clean and clear hurdles and catches to rejuvenate😄

👉 Honest stakeholders know everything but dont open the mouth being obligated.

😜🤪😝🤑

POV: Bhagwan PS

The way Mohalla clinic started in Delhi, Government of India should open pharma clinics across the country on the same line and employ pharmacists to end the unemployment of pharmacists.

The way Mohalla clinic started in Delhi,

Government of India should open pharma clinics across the country on the same line and employ pharmacists to end the unemployment of pharmacists.

If you agree then share 🙏 

POV: Unknown

An Open Letter to Pharmacy Teachers.- Bhagwan PS

An Open Letter to Pharmacy Teachers.

Dear Respected Pharmacy teachers, 

Greetings & Good Wishes.

As we welcome a fresh batch of first-year pharmacy students, we are reminded once again of the profound responsibility placed upon us—not merely to teach subjects, but to shape young minds into competent, ethical, and dependable professionals of tomorrow.

Students in their journey look to us for guidance, not only in academics but also in conduct, values, and professional discipline.

In this journey, our role is more than just delivering lectures; it is about moulding personalities, instilling confidence, and nurturing integrity.

At this stage, I would like to share a few of my thoughts, if you don't mind.

Let us look into needs:

1. Strong Foundations

2. Learning with relevance

3. Discipline and Professional Identity

4. Shaping Attitude Along with 

     Knowledge

5.  Guidance through Challenges

6.  Nurturing Curiosity and Integrity

7.  Be Mentors, Not Just Examiners

8.  Collaborating with community  

Let us avoid encouraging shortcut learning. Insist that students read standard reference books, prepare their own notes, and develop the habit of thinking critically. Quick-fix guides do not build professionals. Let us ensure the foundation we lay is strong and lasting with open end to explore further. 

Subjects in pharmacy often appear abstract to new learners. It is our duty to connect theory with practice—linking anatomy to patient care, pharmaceutics to formulations, pharmacology to rational therapy, and law to professional responsibility. Let us show them the bigger picture of PharmaCare and healthcare delivery.We should never miss any opportunity to orient the issue towards practical application.

We should remind students that pharmacy is a discipline of service and responsibility. Ours is a supportive service to the Healthcare. Healthcare is a team work where Clinician is the Team head or Team leader. Egoistic thoughts and attitude are poisons to the Profession and should be discouraged.

We should impress upon students that the dress code, punctuality, and respect for institutions should not be seen as restrictions but as badges of identity and dignity. We, as teachers, must model this discipline ourselves.

Let us impress upon students that the Marks though are necessary as a scale of achievement, It alone will not make them professionals. A professional should have responsible attitude, humility to learn, and respect for doctors, nurses, and healthcare staff.

Students will face confusion, pressure, and fear of failure. Instead of judging them harshly, we should guide them patiently, show them learning techniques, and encourage perseverance. 

Every doubt clarified and every fear addressed adds strength to their professional journey.

Communication is the working tool of Pharmacists. Verbal communication, Written short and long narrative communications have to be given as exercise to practice.  Let us encourage students to ask questions, debate ideas, and learn from mistakes. Honest inquiry should be welcomed, not discouraged. At the same time, let us stress the values of academic integrity—discouraging malpractice, plagiarism, and unethical shortcuts.

Students remember not the marks we gave, but they do remember our encouragement, advice and inspiration. Our mentorship will stay with them throughout their lives.

We should help students communicate their role as future pharmacists to their families and community. Positive attitude in explaining our role as a supportive Healthcare  team member enhances respect and status. 

Dear Colleagues,

Let us take pride in moulding these young learners into trustworthy professionals who will stand before society with competence and integrity. 

If we give our best with honesty and dedication, our students will carry forward our legacy in the noble profession of pharmacy.

Good luck and good wishes

With Kind regards

Attn: #IPCA, #IPA, #APTI,#IPGA, #PCI,#REGULATORIES,.Dear leaders,Please read your vision, mission statements and objectives of the Associations you are heading and objective of the Act under which you are appointed.Quit the leadership if you have any personal agenda to achieve for enjoyment.- Bhagwan PS (Negative Extreme)

Attn: #IPCA, #IPA, #APTI,#IPGA, #PCI,#REGULATORIES,.

Dear leaders,

Please read your vision,  mission statements and objectives of the Associations you are heading and  objective of the Act under which you are appointed.

Quit the leadership if you have any personal agenda to achieve for enjoyment.

I am finding your discomfort very conspicuous to support and associate with struggling Pharmacists.

You are very well aware that the Pharmacy Act and Drugs&Cosmetics Act are hurdles to the growth of the Pharmacy profession restricts only to dispense across the counter.

Yet, it has never occurred to you propose for necessary Amendments to ensure fulfledged professional service to the public and HealthCare system or propose for a separate Legislation to bring out 'Pharmacy Practice Act & Rules' 

Even Doctors and advocates get down to streets when they find some injustice to them happening.

But you leaders in Ivory towers are so indifferent  and cleverly deaf&dumb to react even when a heavy hammer falls on common pharmacist.

Your ceremonial  presence is well registered in all celebrations and 5 star meetings and you never miss  photo opportunities.

At the same time your absence physically and even morally is conspicuous when pharmacists are struggling for survival, against onslaught of law, against support being given by PCI and DcDs to licensees to violate the law.

99.9% of the pharmacists in and out of India have neither trust nor faith on your Associations and our Councils

These (your)  registered bodies have become a lucrative domain for a few to enjoy the luxury by organizing Bakwas meets.

Pharmacy teachers have no trust on APTI as APTI has betrayed the teachers and majority of them are underpaid with no respect and service security,

Pharmacy Graduates are disgusted with quality of education as they are not getting job worthy professionals.

Well,  Please introspect and come out of your cool Comfort zones to chalk out a common good roadmap to save the pharmacy profession which you have made a sinking ship loaded with millions of labelled pharmacists, Lest, common pharmacists will make you tumble down from your #IvoryTower.

Dear Respectable and knowledgeable CDSCO,- Bhagwan PS (Sarcasm)

Dear Respectable and knowledgeable  CDSCO,

I appreciate the very novel professional exemplary decisions you have been taking.

I think you have missed the fact or your medical and administrators have failed to notice that Sch K amendment, Chemist to Pharmacy amendment, Brand and Generic Sale merging amendment without ensuring Pharmacists presence etc terminal switche at:WERE NOT AT ALL REQUIRED 😄.- An unnecessary exercise!

If you think and apply your wisdom you will notice one #MainSwitch that can be operated instead of terminal switches to achieve your noble goal.

With that switch you will be doing the great service to the public and perhaps would be appreciated personally by Sri Modiji too🎉.

That #MainSwitch is.....?

- A simple amendment to Drugs & Cosmetics Act to delete  #PharmacistRequirement for Retail & Wholesale Drug Trade License.

CDSCO should Recommend to delete the Requirement of the "PHARMACIST" for Pharmacy license both in Government and Private sectors.

Thus, with One stroke you will:

a. Delete Sch K. wrt Pharmacists.

b. Deletes Corruption factor at:

i.  licensing and Inspection level.

ii  Pharmacy college sanctioning and Seats approval level

iii. Pharmacy Colleges inspection and Renewal level.

c.  Removes the agony of Pharmacists at the hands of State Councils for Registration, Renewal etc..

Further, you will be helping millions of 10+ and 10+2 students to chose better course and career.

Thank you,

Regards.

Pov: Bhagwan PS

An Open letter to 1st yr Pharmacy students.Dear Students,

An Open letter to 1st yr Pharmacy students.

Dear Students,

I welcome you to this new chapter of your life. Stepping into a professional course is an important milestone, and it is natural to feel a mix of excitement and uncertainty.

At this stage, I want to share something simple but essential:

success in your journey here does not come from shortcuts, nor does it come from being overly anxious about the future. It comes from honest and dedicated study, day by day, step by step.

Strictly avoid shortcut books like Guides, Q&A booklets. They are like junk fast-foods giving immediat taste but fail to provide strong foundation for the future. Read reference books and prepare your own notes.

Every profession demands a foundation of discipline, and pharmacy is no exception. Good professional career cannot be built on poor quality foundation.

The subjects you will study may sometimes feel heavy or even distant from immediate application. But as you move forward, you will realize that each piece of knowledge—whether in anatomy, pharmaceutics, pharmacology, or law—connects to the bigger picture of patient care and responsible Pharmacare practice.

Challenges cannot be wished away, Accept them Exams may feel tough, concepts may sometimes appear confusing, and the workload may seem demanding. But remember—these are not barriers meant to block you; they are tests that shape you for a good professional career. If you face them with sincerity, you will emerge stronger and more capable professional.

A good, respectable professional life is built on the values of integrity, responsibility, and perseverance. Your learning here is not just about marks; it is about preparing yourself to stand confidently before patients, society, and the healthcare system as a Trustworthy professional.

Never forget your dress code. Its your companion through out your life. Its your identity and be proud to wear it at all workplace.

So, Attend to your studies with seriousness without fear, Seek clarity, ask questions, and never hesitate to learn from teachers, peers, or even from mistakes.

Balance your academics with healthy habits and positive friendships.

If you give your best with honesty and dedication, your future will take care of itself. Let your years here be a time of growth, curiosity, and preparation for a meaningful professional career.

Explain to your parents your profession and be a healthCare partner to your family.

Respect Healthcare institutions, Doctors, Nurses and all staff therein.

Avoid egoistic attitude.

Good luck & Good Wishes 👍

Pov: Bhagwan PS

#Pharmacist - Kaha ka? - Neither for Industry nor for Healthcare

#Pharmacist - Kaha ka?

    - Neither for Industry nor for Healthcare

Pharmacists in India face a stark reality: 

There is no exclusivity for them in pharmaceutical industry, R&D, or marketing. Except Diploma Pharmacists graduates and even Clinical Pharmacists with PharmD have no slots to serve in Healthcare

Then, what for these courses are conducted to ruin the life of young aspiring Pharmacists?

 With thousands of colleges producing an overwhelming number of graduates each year, industry is not a viable source of employment.

Shockingly, the IPC which is a conglomeration of IPA, IGPA, APTI, IHPA and PCI has never considered this issue to evolve a solution, inspite of repeatedly voicing the need. 

Irony is IPC wants huge number of Pharmacists from various streams to attend and participate in various activities! but seldom addresses their issues since 1968.

Adding to this crisis are restrictions in our very laws:

Drugs & Cosmetics Act, 1940 does not grant pharmacists exclusive rights in manufacturing, R&D, or marketing; wholesale drug licenses can go to non-pharmacists; even in retail, ownership lies with anyone, with pharmacists reduced to mere signatories. Clinical roles such as counseling or therapy monitoring are not mandated at all.

Pharmacy Act, 1948 is confined largely to registration. Unlike doctors or nurses, pharmacists have no statutory role in patient care. Dispensing is mandatory only on paper—weak enforcement allows rampant proxy practice. Education provisions remain outdated, failing to orient graduates to healthcare needs.

This legal framework leaves them in “Na ghar ka, na ghat ka”—neither industry-recognized nor healthcare-anchored. Yet authorities, academicians, and faculty remain indifferent, even as NAAC delists pharmacy from Health Sciences.

The way forward lies in restructuring. We need intellectually smart teachers to shape smart pharmacists. 

Healthcare is the only sector with infinite potential to absorb all category of Pharmacists —from dispensing to logistics to clinical pharmacy which all together is PharmaCare support to healthCare.

Every hospital unit requires at least one clinical pharmacist and one or two chief pharmacists, besides diploma pharmacists. To make this a reality, pharmacy must be firmly recognized as a Health Science, with education restructured to produce competent professionals.

Since PCI has taken up the task of Updating the B. Pharm Curriculum it should seriously consider to incorporate all activities required to support HealthCare under PharmaCare.

Further, the Profession needs a Supportive laws. Hence, a separate law "#PharmacyPracticeRegulationAct should be legislated that empowers  the Pharmacist with due Accountability. This will eradicate the menace of Certificate renting, Absentee Pharmacist, Corruption arising out of this violation. 

#PCI

#APTI

#IPA

#IPC2025

#Pharmacist 

#Industry 

#Healthcare

POV: Bhagwan PS

One Syllabus One Book For All Courses

#OneSyllabusOneBookForAllCourses

I came across some advertisement of Books on Anatomy, Physiology, Jurisprudence, Pharmaceutics, Pharmacology etc claiming that it is for D Pharm and B Pharm. As we go through the syllabus we find the same content.

Does this mean both study the same, Knowledge is same, depth is same?

                          ***

A “One Book for All” approach though is convenient to the Author and gets better sales is usually oversimplified marketing—helpful for surface-level basics, but insufficient for B Pharm-level depth.

It is high dose to D Pharm and sub-dose to B Pharm.

Ideally, separate standard textbooks (or at least editions with differentiated depth) are needed

Pov: Bhagwan PS

VisionOfTheIndianPPRAct- Bhagwan PS

#MyVisionOfTheIndianPPRAct

Given the persistent failure of institutions and systems to provide fair, deserved opportunities to qualified pharmacists, an exclusive legislation with clear empowerment and accountability has become essential.

The Pharmacy Practice Regulations (PPR) Act is envisioned as the legal and professional backbone for safe, effective, and ethical pharmaceutical care in India. It will authorize pharmacists as direct patient care providers, backed by professional accountability, standard operating procedures, and defined service delivery models—integrating them seamlessly into the healthcare continuum.

Under the PharmaCare Clinical Support System, the Act applies across all professional tiers—D Pharm, B Pharm, M Pharm, and PharmD—with structured, competency-based roles:

1. #DiplomaInPharmacy (D Pharm):

Frontline dispensers and community care providers. Trained in medication handling, prescription verification, OTC guidance, and basic counselling. Accountable for legal dispensing, adverse event reporting, and prescription record maintenance.

2. #BachelorOfPharmacy (B Pharm):

Advanced technical and operational support. Skilled in dosage form optimisation, supply chain integrity, pharmacovigilance, and rational drug use promotion. Authorized to conduct prescription audits, assist in therapeutic substitutions under protocol, and support primary care clinics in medication therapy management.

3. #MasterOfPharmacy (M Pharm – Pharmacy Practice / Clinical / Hospital Pharmacy):

Specialised medication experts in clinical decision support, formulary management, and interprofessional collaboration. Lead quality improvement programs, train juniors, develop evidence-based protocols, and support health technology assessment initiatives.

4. #DoctorOfPharmacy (PharmD):

Apex patient-care pharmacists integrated into clinical teams. Conduct medication histories, identify and resolve drug-related problems, perform therapeutic drug monitoring, and provide evidence-based therapy recommendations. Drive clinical governance, patient safety initiatives, and pharmacare research.

The #PPRAct’s PharmaCare model creates a continuous patient-care chain where each cadre complements the next—ensuring medication use is safe, effective, and cost-efficient. It mandates standardised documentation, ICT-enabled monitoring, and continuous professional development to maintain competence.

Ultimately, the Act positions pharmacists as indispensable members of healthcare teams—bridging the gap between prescription and patient outcomes, reducing medication errors, and improving public health metrics. It shifts pharmacy practice from a supply-driven role to a patient-centred, outcome-oriented healthcare service—securing the pharmacist’s place as a critical partner in India’s healthcare service system.

Pov: Bhagwan PS

#PharmacyPracticeRegulationAct is in the urgent need to support the collapsing #PharmacyProfession.

#PharmacyPracticeRegulationAct is in the urgent need to support the collapsing #PharmacyProfession.

POV: Bhagwan PS

Drugs Law &Pharmacy Law are the main bottleneck preventing Pharmacists from delivering professional service..#DrugsRegulatory, #PCI, #APTI

Drugs Law &Pharmacy Law are the main bottleneck preventing Pharmacists from delivering  professional service..

#DrugsRegulatory, #PCI, #APTI

POV: Bhagwan PS

the right value is given only in the right place. If you are not valued, it doesn’t mean you are worthless — it only means you are standing in the wrong place.

Dear PharmDs, 

Let me tell you a short story.

An aged father once told his daughter: “I have nothing to give you except the old car standing outside. Before selling it, take it to different places and see how much people value it.”

The daughter took the car first to a dealer — he said it was too old, worth very little. Then to a shopkeeper — he offered a little more, just out of kindness. Finally, she showed it to a museum. The curator exclaimed, “This is a rare classic, priceless! We will pay you a fortune.”

The father then said, “My child, the right value is given only in the right place. If you are not valued, it doesn’t mean you are worthless — it only means you are standing in the wrong place.”

Friends, this is exactly the condition of our young pharmacists today. Many feel undervalued and frustrated. In some hospitals, they are treated merely as dispensers. In others, a little better as support staff. 

But when the system understands your expertise in medicines, patient safety, and therapy optimization — will be recognized as an  indispensable member of the healthcare team.

Now, the good news is that 'The All India PharmDs Association® (AIPDA) is bringing on the cards the PharmaCare Clinical Support System — a platform to approach Government of India with a well planed presentation and a Memorandum and to request to start 'Pharmacare Clinical Clinical support' department' in selected hospitals as a Pilot Project where pharmacists where your skills in drug information, evidence-based support, and clinical care will be recognized as essential for better patient outcomes.

Friends, the message is clear:

👉 Our value does not diminish because someone fails to recognize it.

👉 It is our responsibility to give moral push to our students, our young professionals, to move towards the right platforms, to innovate, to prepare, and to be part of systems like PharmaCare where their true worth will shine.

Let us not lament. Let us stand united and strengthen the AIPDA to negotiate intellectually with the Government to make 'Pharmacare' concept a reality.

Join AIPDA today!

Thank you.

POV: Bhagwan PS

Accutane(isotretinoin) coverage depends on your specific health insurance and often requires a prior authorization, where your dermatologist must prove you've tried other treatments first.

Accutane (isotretinoin) coverage depends on your specific health insurance plan and often requires a prior authorization, where your dermatologist must prove you've tried other treatments first. Your insurer may prefer or only cover the less expensive generic versions, and you will likely still be responsible for costs like co-pays and lab fees. To confirm coverage and costs, contact your insurance provider and doctor before starting treatment. 

Key considerations for insurance coverage: 

• Prior Authorization:

  Most insurance plans require this process for isotretinoin, where the insurer and your doctor discuss your treatment and approve it.
• Generic vs. Brand-Name:

  Insurers often prefer generic forms of isotretinoin (like Claravis or Myorisan) over the brand-name Accutane.
• Additional Costs:

  Even with insurance, you may have to pay for lab tests, monthly doctor visits, and co-pays.
• Check Before You Start:

  Always verify coverage and potential costs with your insurance company and doctor before beginning the prescription.

What to do if your insurance denies coverage:

• Review the Denial:

  Carefully read the denial letter to understand the specific reason for the decision. 
• Contact Your Insurance:

  Speak with your insurance provider to learn more about the requirements. 
• Appeal the Decision:

  You can appeal the denial by providing additional information or working with your doctor to submit a strong case. 
• Explore Alternatives:

  If Accutane is not covered, discuss alternative acne treatments with your dermatologist. 
• Look for Savings Programs:

  For commercial plans, you might be able to use a manufacturer's savings card to reduce your out-of-pocket costs for Teva's isotretinoin. 

Phamacy Council Election

#PhamacyCouncilElection

All ills of Pharmacy councils are due to syndicate grouping of Yes-Men who preplan #MatchFixMeetings and Resolutions.

Hence, Tips to Voters:

👉Do not vote for all in one group.

- They become Yes-Men to their leader to flout all Rules and Regulations and it may lead to loot funds.

👉 Pick Good People from each group and do not ignore independents.

👉 Keep the elected members answerable to the Regd Pharmacists.

Good wishes

POV: Bhagwan PS

'Profession Vs Job' - Professional standards do not compromise whereas Job standards can be compromised.!

'Profession Vs Job'

Professional standards do not compromise whereas Job standards can be compromised.!

Making M Pharm equally eligible as Pharm D for Clinical Pharmacist post has Compromised the Profession.

Hence #NotAWiseMove.

A post in a Wtsp group:

    "Dear Sir/Madam, In a major relief to MPharm degree holders, the Union government has decided to include MPharm (pharmacy practice) as a sufficient qualification for appointing clinical pharmacists to hospitals. The government clarified its stance in the High Court in response to a batch of writ petitions filed by various MPharm degree holders.

Justice Viju Abraham, who considered the petitions, directed the government to implement the decision within three months. Earlier, the government had excluded MPharm as the eligible qualification for serving as clinical pharmacists in hospitals through an amendment brought to the Pharmacy Practice Regulations Act in 2019. Through this amendment, the government made doctor of pharmacy (Pharm D) the qualification for the post."

PCI committed the same blunder while starting B Pharm keeping D Pharm alive.

Had the D Pharm been closed the Hospital Pharmacy would have been in a strong position by now in health

sector.

This is result of having professionally unqualified people in authority.

Pov: Bhagwan PS

Vision Of The Indian PPR Act by Bhagwan PS

#MyVisionOfTheIndianPPRAct

Pov: Bhagwan PS

Given the persistent failure of institutions and systems to provide fair, deserved opportunities to qualified pharmacists, an exclusive legislation with clear empowerment and accountability has become essential.

The Pharmacy Practice Regulations (PPR) Act is envisioned as the legal and professional backbone for safe, effective, and ethical pharmaceutical care in India. It will authorize pharmacists as direct patient care providers, backed by professional accountability, standard operating procedures, and defined service delivery models—integrating them seamlessly into the healthcare continuum.

Under the PharmaCare Clinical Support System, the Act applies across all professional tiers—D Pharm, B Pharm, M Pharm, and PharmD—with structured, competency-based roles:

1. #DiplomaInPharmacy (D Pharm):

Frontline dispensers and community care providers. Trained in medication handling, prescription verification, OTC guidance, and basic counselling. Accountable for legal dispensing, adverse event reporting, and prescription record maintenance.

2. #BachelorOfPharmacy (B Pharm):

Advanced technical and operational support. Skilled in dosage form optimisation, supply chain integrity, pharmacovigilance, and rational drug use promotion. Authorized to conduct prescription audits, assist in therapeutic substitutions under protocol, and support primary care clinics in medication therapy management.

3. #MasterOfPharmacy (M Pharm – Pharmacy Practice / Clinical / Hospital Pharmacy):

Specialised medication experts in clinical decision support, formulary management, and interprofessional collaboration. Lead quality improvement programs, train juniors, develop evidence-based protocols, and support health technology assessment initiatives.

4. #DoctorOfPharmacy (PharmD):

Apex patient-care pharmacists integrated into clinical teams. Conduct medication histories, identify and resolve drug-related problems, perform therapeutic drug monitoring, and provide evidence-based therapy recommendations. Drive clinical governance, patient safety initiatives, and pharmacare research.

The #PPRAct’s PharmaCare model creates a continuous patient-care chain where each cadre complements the next—ensuring medication use is safe, effective, and cost-efficient. It mandates standardised documentation, ICT-enabled monitoring, and continuous professional development to maintain competence.

Ultimately, the Act positions pharmacists as indispensable members of healthcare teams—bridging the gap between prescription and patient outcomes, reducing medication errors, and improving public health metrics. It shifts pharmacy practice from a supply-driven role to a patient-centred, outcome-oriented healthcare service—securing the pharmacist’s place as a critical partner in India’s healthcare service system.

PCI to integrate pharmacists' database with Healthcare Professional Registry

Gireesh Babu, New Delhi Saturday, November 23, 2024, 08:00 Hrs  [IST]

The Pharmacy Council of India (PCI) has sought all the pharmacists who don't have the ABHA (Ayushman Bharat Health Account) number to attain a number and ensure registration with the DIGI-PHARMed profile with the ABHA number on immediate basis, as part of its efforts to integrate the pharmacists' list with the Healthcare Professional Registry (HPR). The Council is in the process of verification of all registered pharmacists on the DIGI-PHARMed portal in order to integrate pharmacists with the HPR, and asked all the pharmacists to consider certain action points in order to equip the Council for a smooth integration. "All registered pharmacists are requested to verify their DIGI-PHARMed profile with the ABHA Number on immediate basis. The said verification must be completed within the timeline of 45 days from the date of issuance of this circular," said the Council in a communication to all registered pharmacists. "Failing to this, the pharmacist's profile will be disabled for any further usage on the DIGI-PHARMed portal," it added. In case of new registration, pharmacists must ensure to verify their account with the ABHA number at the time of registration and without verification of the profile with this number will be considered as incomplete registration. If the pharmacists don't have the ABHA number, it is directed to create the ABHA number using Aadhar before initiating the process or the registration of DIGI-Pharmed portal. The Council also requested to all the pharmacy institutions as well to check that all the faculty in their institutions are having the ABHA verified profiles and notified that during the Standard Inspection Format (SIF) applications and for further reference, only ABHA verified profiled of faculty will be considered by the Council from 2025-26 academic session, it added. It also directed all pharmacists that they must ensure that the documents uploaded to the portal while registering are authentic and validated. "If the Council discovers at any stage that any documents submitted during the registration process are incorrect, the respective profile of those pharmacists will be blacklisted," said the Council. In case of any inconvenience or technical issues, the pharmacists or the institutions can share the issues over email to the Council or reach out over telephone, it added. Healthcare Professionals Registry is a comprehensive repository of registered and verified different system of medicines (modern medicine, dentistry, Ayurveda, Unani, Siddha, Sowa-Rigpa, Homoeopathy) and nurses practitioners delivering healthcare services across India.  The ABHA number will be used for the purposes of uniquely identifying persons, authenticating them, and threading their health records (only with the informed consent of the patient) across multiple systems and stakeholders The repository is part of the Ayushman Bharat Digital Mission (ABDM), which empowers healthcare professionals to be part of India’s digital health ecosystem through a unique healthcare professional ID. With last mile coverage, people will be able to interact with healthcare practitioners or vice versa. Healthcare professional profile visible in the ABDM ecosystem is verified and authorised to practice medicine in the country. The HPR ensures that healthcare practitioners suitably trained and qualified to practice medicine with competence and ethical conformity are allowed to register with the HPR. Pharmacists are HealthCare Professionals. Lets be worth it. Really!!!,  then why the term ' PharmaCare ' was coined. Pharmacist A HealthCare professional? If so why pharmacy course is not?. Has the Pharmacy education been got included in National Health Education Manual? ok

So many regulatory bodies and governing bodies in pharmacy education: whims of my mind

PCI(Pharmacy Council Of India) and AICTE(All India Council for technical education) are the governing bodies in the pharmacy education , keeping in mind the compounding and dispensing as well as the technical aspects involved in Pharmaceutical Engineering .

Now with the advent of Pharm D course in pharmacy, which is clinically oriented 6 years course in pharmacy and the syllabus is designed such as  first 3 years are same as B.Pharm ( compounding and dispensing oriented) and next 2 years are same as MD Pharmacology (medically and clinically oriented) and 1 year of internship in an attached (minimum- 300 beded) hospital , one may expect MCI (medical council of India) to get into the thick of the things/matters.

As it requires an affiliation with a  hospital( minimum 300 beded), to get approval for an pharmaceutical institute from PCI to conduct the course , one must expect MCI(medical council of India)(Now NMC) also to get involved as a regulatory and governing body.

PCI governs courses like : D.Pharm
                                         B.Pharm
                                        Pharm D and Pharm D(PB)

AICTE governs courses like : B.Pharm( jointly with PCI)
                                              M.Pharm

Now one must expect AICTE,PCI and MCI may jointly govern : Pharm D and Pharm D(PB)

But no, its not a rational thinking on my part. MCI (Now NMC ) will get involve only when the course is a medical one or may be when the professional doctor is dealing with a body part.
So, its fair enough that MCI(NMC) is not involved into these matters.(Really?!!!)

                                             

Pharm D course introduction and D Pharma course closure is Propaganda !!! Is Pharm D and Pharm D(PB) course is approved by UGC?

I don't understand why D. Pharma course is being removed as minimum qualification for registration to practice Pharmacy in India. 

They say due to corruption. (Propaganda)

But I have seen corruption and malpractices happening at higher education level as well. 

1)PhD and PharmD students/interns publishing their names in scientific journals for research articles in which they have not done anything and just paid asked amount to the principal researcher so that their name get added in the research article as co-authors or co-researchers for publishing in scientific journals.

2)illogical sequence of subjects taught at colleges with these newly started courses.

3)Renting of license will continue even on Pharm-D ( doctor of pharmacy) degree.

4)To make minimum qualification for a registered pharmacist to do pharmacy practice in India, Pharm-D degree rather than D.Pharm ie. to replace the state's diploma of pharmacist.

Instead of updating and upgrading the syllabus of D.Pharm, what the policy makers have done is that they have created a new course named Pharm.D/Pharmd(PB) and obvious plan is to make it the minimum qualification for a registered pharmacist to do pharmacy practice in India and produce so called Next Generation and New Age Pharmacist. It's like a RESTART button pressed on.

Why create so much confusion, why malign the integrity of Pharmacy field. They could have retained the D.Pharm course and should have made neccessary changes in the syllabus and duration of D.Pharm, so that the minimum qualification for a registered pharmacist to do pharmacy practice in India remain D.Pharm and no need to replace the state's diploma of pharmacist. 

Just imagine if M.B.B.S course is replaced by some other course which is made minimum qualification for a registered physician to do medical practice in India.

And then they call themselves Pharma Expert or Drug Expert (DRX). What a pity situation ?

Is Pharm D and Pharm D(PB) course is approved by UGC? 

Medical Science vs Pharmaceutical Science (Residential Program Year)

RPY: Residential Program Year

Pharmacy residency is education a pharmacist can pursue beyond the degree required for licensing as a pharmacist (in the United States of America: PharmD). A pharmacy residency program allows for the implementation of skill set and knowledge acquired in pharmacy school through interaction with the public either in a hospital setting or community practice.The program is done over a span of about two years after graduation from pharmacy school and licensure as a pharmacist. Pharmacy residency helps improve the resume of a pharmacist so as to increase chances of obtaining employment outside community practice. A 2022 review suggested that there is sufficient evidence that residency develops key competencies for junior pharmacists

In India, after completing a Pharm.D. (Doctor of Pharmacy) degree, students can pursue residency programs to specialize in clinical pharmacy or related fields, enhancing their expertise and career prospects. These programs, often lasting one to two years, provide advanced training in areas like clinical pharmacy practice, patient care, and drug information. 

Details about Pharm.D. and Residency in India:

• Pharm.D. as a Professional Qualification:

  The Pharm.D. is a professional doctorate recognized by the Pharmacy Council of India (PCI). It signifies expertise in pharmacy practice and allows graduates to become licensed pharmacists. 
• Residency Programs:
• Following the Pharm.D., residency programs offer specialized training in various clinical settings, such as hospitals and clinics. 
• Focus Areas:
• Residency programs can focus on areas like:

  • Clinical Pharmacy: Providing patient-centered care, medication therapy management, and drug information services. 
  • Critical Care: Managing patients in intensive care units, focusing on advanced life support and critical care protocols. 
  • Other Specializations: Opportunities may also exist in areas like oncology, cardiology, and infectious disease, depending on the specific program and institution. 
  • Career Paths:
• Residency training can lead to various career opportunities, including:

  • Clinical Pharmacist Roles: In hospitals and other healthcare settings, directly involved in patient care. 
  • Medical Affairs: Bridging the gap between pharmaceutical companies and healthcare professionals, providing scientific expertise and support. 
  • Research: Participating in clinical trials and research activities.   
  •  Duration:Residency programs typically last one to two years, depending on the specialization and institution. 
• Benefits:Residency programs offer valuable practical experience, enhance clinical skills, and improve career prospects for Pharm.D. graduates. 

Residency Medicine

Residency or postgraduate training is a stage of graduate medical education. It refers to a qualified physician (one who holds the degree of MD, DO, MBBS/MBChB), veterinarian (DVM/VMD, BVSc/BVMS), dentist (DDS or DMD), podiatrist (DPM), optometrist (OD), pharmacist (PharmD), or Medical Laboratory Scientist (Doctor of Medical Laboratory Science) who practices medicine or surgery, veterinary medicine, dentistry, optometry, podiatry, clinical pharmacy, or Clinical Laboratory Science, respectively, usually in a hospital or clinic, under the direct or indirect supervision of a senior medical clinician registered in that specialty such as an attending physician or consultant.

The term residency is named as such due to resident physicians (resident doctors) of the 19th century residing at the dormitories of the hospital in which they received training.^[1]

In many jurisdictions, successful completion of such training is a requirement in order to obtain an unrestricted license to practice medicine, and in particular a license to practice a chosen specialty. In the meantime, they practice "on" the license of their supervising physician. An individual engaged in such training may be referred to as a resident physician, house officer, registrar or trainee depending on the jurisdiction. Residency training may be followed by fellowship or sub-specialty training.^[2]

Whereas medical school teaches physicians a broad range of medical knowledge, basic clinical skills, and supervised experience practicing medicine in a variety of fields, medical residency gives in-depth training within a specific branch of medicine.

In India, medical residency, also known as postgraduate training, typically lasts for 3 years after completing the MBBS degree. It's a period of intensive clinical training in a chosen specialty, preparing doctors for independent practice. The residency program is structured with academic coursework, clinical rotations in various departments, and research components, culminating in an MD or MS degree (depending on the specialty). 

Key aspects of medical residency in India:

Duration: Generally 3 years for most specialties, but can vary. 


Eligibility: Requires completion of MBBS and passing the NEET-PG exam. 


Structure: Includes clinical rotations, academic learning (case discussions, seminars, etc.), and research. 


Focus: Hands-on clinical experience and development of practical skills under supervision. 


Outcome: Leads to an MD or MS degree in the chosen specialty and prepares doctors for independent practice. 


Supervision: Residents work under the guidance of attending physicians and consultants. 


Workload: Residents typically work long hours, including nights, weekends, and holidays. 

Is Pharm D and Pharm D(PB) course is approved by UGC?

University Grants Commission (UGC) is a statutory body under Department of Higher Education, Ministry of Education, Government of India. It was set up in accordance to the UGC Act 1956 and is charged with coordination, determination and maintenance of standards of higher education in India. It provides recognition to universities in India, and disbursements of funds to such recognized universities and colleges. The UGC headquarters are in New Delhi, and it has six regional centres in Pune, Bhopal, Kolkata, Hyderabad, Guwahati and Bengaluru. A proposal to replace it with another new regulatory body called HECI is under consideration by the Government of India. The UGC provides doctoral scholarships to all those who clear JRF in the National Eligibility Test. On an average, each year ₹725 crore (US$86 million) is spent on doctoral and post-doctoral fellowships by the commission.

Pharmacists are Healthcare Professionals or Pharmacare Professionals?

Pharmacists are HealthCare Professionals.

Lets be worth it.

Really!!!,  then why the term ' PharmaCare ' was coined.

Pharmacist A HealthCare professional? If so why pharmacy course is not?. Has the Pharmacy education been got included in National Health Education Manual?

Someone kindled me to define and explain who is Healthcare professional? Where does the Pharmacist fit in?

Healthcare Professional.

Someone kindled me to define and explain who is Healthcare professional? Where does the Pharmacist fit in?

Not an easy question in light of Second question.

Any professional who serves the humans to safeguard his / her health and serves to mitigate the suffering and assists and supports the patient to be as comfortable as possible and treats him directly and fecilitates treatment could be called healthcare professional or Health Worker. All put together could be called a Medical Team

[This is my own extempore definition, I am subject to correction]

Now coming to second question,

Where does the Pharmacist fit in to be called Healthcare professional?

Excluding Pharm D Pharmacists, considering prevailing scenario and practice in India  the Pharmacist looks like a supporter external to the Treatment team  only to dispense what is advised. 

Unless the Pharmacists update themselves  or Course content is updated to familiarise the students on healthcare practices in preventive and curative services Pharmacists of India may not gain the Healthcare Professional tag.

#PCI, #IPA, #APTI,

POV :Bhagwan PS

Pharmacists are HealthCare Professionals.

Lets be worth it.

Really!!!,  then why the term ' PharmaCare ' was coined.

Pharmacist A HealthCare professional? If so why pharmacy course is not?. Has the Pharmacy education been got included in National Health Education Manual?